These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4920429)

  • 21. Five years of clinical experience with rifampicin.
    Gyselen A; Cosemans J; Lacquet LM; Vandenbergh E; Verbist L
    Acta Tuberc Pneumol Belg; 1971; 62(4):289-307. PubMed ID: 4948635
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anatomo-bacteriological criteria of the effect of rifampicin in the treatment of pulmonary tuberculosis].
    Morère P; Stain JP; Hubert J; Chauvet MC
    Rev Tuberc Pneumol (Paris); 1970; 34(5):714. PubMed ID: 5496794
    [No Abstract]   [Full Text] [Related]  

  • 23. [A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis].
    Firsova VA; Poluektova FG; Kuz'min AV; Chernousova LN
    Probl Tuberk Bolezn Legk; 2004; (8):28-30. PubMed ID: 15478555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental and clinical studies of rifampicin in tuberculosis.
    Konno K; Oizumi K; Hayashi I; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resumption of treatment by rifomycin of resistant cases of pulmonary tuberculosis].
    Destexhe GE
    Acta Tuberc Pneumol Belg; 1969; 60(3):501-6. PubMed ID: 5371674
    [No Abstract]   [Full Text] [Related]  

  • 27. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 28. Rifampin in the treatment of drug-resistant TB.
    Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
    Md State Med J; 1971 Jun; 20(6):79-80. PubMed ID: 5141742
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new antitubercular agent: rifampicin].
    Favez G
    Schweiz Rundsch Med Prax; 1970 Feb; 59(8):296-7. PubMed ID: 4996719
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug treatment of tuberculosis.
    Steiner M
    N Y State J Med; 1984 Jun; 84(6):294-5. PubMed ID: 6589508
    [No Abstract]   [Full Text] [Related]  

  • 32. [3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
    Hennebert A
    Acta Tuberc Pneumol Belg; 1969; 60(3):507-12. PubMed ID: 5371675
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative bacteriological development in 2 groups of patients with severe pulmonary tuberculosis, 1 treated with a rifampicin-base combination, the other with an INH-base combination].
    Augier J; Parrot R; Marchal G; Gillet P
    Rev Tuberc Pneumol (Paris); 1969; 33(3):414-23. PubMed ID: 5383011
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacteriological evolution established in 406 tuberculosis patients treated with various combinations with or without rifampicin or INH].
    Parrot R; Augier J; Auroy C; Baron A; Boscus M; Deshais B; Gillet P; Laparre C; Marchal G; Naghavi H; Plawner S; Schoepff G
    Rev Tuberc Pneumol (Paris); 1970; 34(5):709-13. PubMed ID: 5496793
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic effect of Rifampicin on re-treatment cases of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):227-35. PubMed ID: 5449510
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary results with rifampicin in the treatment of drug-resistant tuberculosis.
    Pines A
    Tubercle; 1969 Mar; 50():Suppl:50-2. PubMed ID: 5402545
    [No Abstract]   [Full Text] [Related]  

  • 38. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic failure in the application of rifampin (RFP): evaluation and management].
    Yamazaki M
    Kekkaku; 1983 Sep; 58(9):498-501. PubMed ID: 6420604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.